» Articles » PMID: 7247363

In Vitro Susceptibility of Salmonella to Various Antimicrobial Agents, Including a New Cephalosporin, Ro 13-9904

Overview
Specialty Pharmacology
Date 1981 Jan 1
PMID 7247363
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The in vitro susceptibility of 363 strains of Salmonella isolated in Honk Kong to various antimicrobial drugs was tested, and the minimum inhibitory concentrations of ampicillin, mecillinam, and six cephalosporins (cephalexin, cephradine, cefamandole, cefoxitin, cefuroxime, and Ro 13-9904) for these strains were determined by an agar dilution method. Although strains of the typhoid and paratyphoid group remained susceptible to most antibiotics tested, many strains of the gastroenteric group of salmonellae were found to be resistant to multiple antibiotics, including ampicillin, chloramphenicol, and, occasionally, trimethoprim. Mecillinam and cefamandole, although active against most of the Salmonella strains tested, were shown to be less active against ampicillin-resistant strains. By contrast, Ro 13-9904 exhibited remarkably uniform and high activity against all the Salmonella strains tested, irrespective of their ampicillin resistance.

Citing Articles

Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.

Pollock A, Tee P, Patel I, Spicehandler J, Simberkoff M, Rahal Jr J Antimicrob Agents Chemother. 1982; 22(5):816-23.

PMID: 6295268 PMC: 185666. DOI: 10.1128/AAC.22.5.816.


Ceftriaxone: in vitro studies and clinical evaluation.

Gnann Jr J, Goetter W, Elliott A, Cobbs C Antimicrob Agents Chemother. 1982; 22(1):1-9.

PMID: 6289734 PMC: 183664. DOI: 10.1128/AAC.22.1.1.


In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.

Beskid G, Christenson J, Cleeland R, DeLorenzo W, TROWN P Antimicrob Agents Chemother. 1981; 20(2):159-67.

PMID: 6269487 PMC: 181657. DOI: 10.1128/AAC.20.2.159.


Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection.

Anton P, Kemp J, Butler T, Jacobs M Antimicrob Agents Chemother. 1982; 22(2):312-5.

PMID: 6100426 PMC: 183731. DOI: 10.1128/AAC.22.2.312.


Ceftriaxone therapy in bacteremic typhoid fever.

Ti T, Monteiro E, Lam S, Lee H Antimicrob Agents Chemother. 1985; 28(4):540-3.

PMID: 4073877 PMC: 180301. DOI: 10.1128/AAC.28.4.540.


References
1.
Butler T, Linh N, Arnold K, Pollack M . Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor. Lancet. 1973; 302(7836):983-5. DOI: 10.1016/s0140-6736(73)91086-6. View

2.
Olarte J, Galindo E . Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrob Agents Chemother. 1973; 4(6):597-601. PMC: 444603. DOI: 10.1128/AAC.4.6.597. View

3.
Anderson E . The problem and implications of chloramphenicol resistance in the typhoid bacillus. J Hyg (Lond). 1975; 74(2):289-99. PMC: 2130376. DOI: 10.1017/s0022172400024360. View

4.
Neu H, CHERUBIN C, Longo E, Flouton B, Winter J . Antimicrobial resistance and R-factor transfer among isolates of Salmonella in the northeastern United States: a comparison of human and animal isolates. J Infect Dis. 1975; 132(6):617-22. DOI: 10.1093/infdis/132.6.617. View

5.
Chun D, Seol S, Cho D, Tak R . Drug resistance and R plasmids in Salmonella typhi isolated in Korea. Antimicrob Agents Chemother. 1977; 11(2):209-13. PMC: 351954. DOI: 10.1128/AAC.11.2.209. View